The statement “Children are not little adults” is a foundation of pediatric drug therapy referring to well-documented differences in pharmacokinetics and pharmacodynamics existing between children and adults. It is, therefore, important to understand the influence of age on drug disposition, especially in neonates and infants, and resulting effects on drug activity. This chapter provides brief discussions of principles of pediatric pharmacokinetics and knowledge of the effects of disease states on disposition of cardiovascular drugs affecting safe and effective drug therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tetelbaum M, Finkelstein Y, Nava-Ocampo AA, Koren G. Understanding drugs in children: pharmacokinetic maturation. Pediatr Rev 2005;26:321–327.
Pal VB, Nahata MC. Drug Dosing in Pediatric Patients. In: Murphy JE, ed. Clinical Pharmacokinetics, 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists, Inc, pp. 439–465, 2001.
Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology—drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157–1167.
Benedetti MS, Blates EL. Drug metabolism and disposition in children. Fund Clin Pharmacol 2003;17:281–299.
Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants. Clin Pharmacokinet 2002;41:1077–1094.
deWildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 1999;37:485–505.
Mann HJ. Drug-associated disease: cytochrome P450 interactions. Crit Care Clin 2006;22:329–345.
Sokol SI, Cheng A, Frishman WH, Kaza CS. Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure. J Clin Pharmacol 2000;40:11–30.
Trujillo TC, Nolan PE. Antiarrhythmic agents. Drug Safety 2000;23:509–532.
Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalized patients—frequent but most clinically insignificant. Eur J Clin Pharmacol 2005;61:675–681.
Malone DC, Hutchins DS, Haupert H, Hansten P, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health-Syst Pharm 2005;62:1983–1991.
Novak PH, Ekins-Daukes S, Simpson CR, Milne RM, Helms P, McLay JS. Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care. Brit J Clin Pharmacol 2005;59:712–717.
Flockhart DA, Tanus-Santos JE. Implications of cytochrome P450 interactions when prescribing medication for hypertension. Arch Intern Med 2002;162:405–412.
Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004;4:281–297.
Stump AL, Mayo T, Blum A. Management of grapefruit-drug interactions. Amer Family Physicians 2006;74:605–608.
Rodighiero V. Effects of liver disease on pharmacokinetics. Clin Pharmacokinet 1999;37:399–431.
Veltri MA, Neu AM, Fivush BA, Parekh RS, Furth SL. Drug dosing during intermittent hemodialysis and continuous renal replacement therapy. Pediatr Drugs 2004;6:45–65.
Joy MS, Matzke GR, Armstrong DK, Marx MA, Zarowitz BJ. A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 1998;32:362–375.
Gabardi S, Abramson S. Drug dosing in chronic kidney disease. Med Clin N Am 2005;89:649–687.
Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin 2006;22:255–271.
Hines RN, McCarver DG. Pharmacogenomics and the future of drug therapy. Pediatr Clin N Am 2006;53:591–619.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Howrie, D.L., Schmitt, C.G. (2008). Clinical Pharmacokinetics: Applications in Pediatric Practice. In: Munoz, R., Schmitt, C.G., Roth, S.J., da Cruz, E. (eds) Handbook of Pediatric Cardiovascular Drugs. Springer, London. https://doi.org/10.1007/978-1-84628-953-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-84628-953-8_2
Publisher Name: Springer, London
Print ISBN: 978-1-84628-952-1
Online ISBN: 978-1-84628-953-8
eBook Packages: MedicineMedicine (R0)